Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma

Development of a Model to Predict Liver Decompensation prior to Transarterial Chemoembolization Refractoriness in Patients with Intermediate-Stage Hepatocellular Carcinoma

Introduction: Transarterial chemoembolization (TACE) is the first-line treatment for patients with intermediate-stage hepatocellular carcinoma (HCC). For patients without an adequate response, current finding suggests that treatment with molecular target agents, approved for advanced stage, might pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Joel Ferreira-Silva, Pedro Costa-Moreira, Helder Cardoso, Rodrigo Liberal, Pedro Pereira, Guilherme Macedo
Formato: article
Lenguaje:EN
Publicado: Karger Publishers 2021
Materias:
hepatocellular carcinoma
transarterial chemoembolization
child-pugh class
Diseases of the digestive system. Gastroenterology
RC799-869
Acceso en línea:https://doaj.org/article/530d888250444b439886496927e95d5c
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/530d888250444b439886496927e95d5c

Ejemplares similares